RankAlpha logo
Back to Rankings

XLO

Xilio TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
XLO vs peer average
40/100
XLO vs. peer average (D vs. C)
Grade spread
A 2 · B 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

INCR is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $56.43M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerINCRInterCure
XLO
Xilio Therapeutics
INCR
InterCure
Grade
D
B
Momentum
29
72
Value
57
46
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs INCR

XLO / INCR
Grade Position
Below peers
XLO vs. peer average (D vs. C)
40/100
Momentum
29
INCR
Value
57
XLO
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs XLO
1
INCR
InterCure Ltd Common
B
80/100
-2
2
CNTX
Context Therapeutics Inc Common
A
100/100
-3
3
EDSA
Edesa Biotech Inc Common
F
20/100
+1
4
CRDF
Cardiff Oncology Inc Common
A
100/100
-3
5
IMMP
Immutep Ltd ADR
D
40/100
Even
INCR is the first peer returned for this comparison set.